MedTrace Logo

The Effect of Vitamin D3 Therapy in Post Menopausal Women and Assessment of Changes in Bone Mineral Density After Orally Vitamin D3 Administration

NCT05389943 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2022-05-25

No results posted yet for this study

Summary

a study design based on vitamin D deficiency in postmenopausal women with low bone density. pre-test for BMD will be done then vitamin D oral supplements will be provided for the period of 3 months. Post-test of BMD will explore the results.

Conditions

  • Vitamin D Deficiency

Interventions

DRUG

Oral administration of vitamin D3

the effect of oral supplement in postmenopausal women.

DRUG

Vitamin D3 50000 UNT Oral Capsule

In postmenopausal women with BMD less than 32 ng/ml

DIETARY_SUPPLEMENT

milk, Dietary and life style modifications.

Postmenopausal women with BMD greater than 32 ng/ml

Sponsors & Collaborators

  • Government College University Faisalabad

    collaborator OTHER

  • University of Sargodha

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-05
Primary Completion
2022-08-15
Completion
2022-11-15
FDA Drug
Yes

Countries

  • Pakistan

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05389943 on ClinicalTrials.gov